4.7 Article

Rapid Sequestration of Leishmania mexicana by Neutrophils Contributes to the Development of Chronic Lesion

Journal

PLOS PATHOGENS
Volume 11, Issue 5, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.ppat.1004929

Keywords

-

Funding

  1. Swiss National Foundation [310030.146187/1, PDFMP3-129700/1]
  2. Swiss National Science Foundation (SNF) [PDFMP3_129700, 310030_146187] Funding Source: Swiss National Science Foundation (SNF)

Ask authors/readers for more resources

The protozoan Leishmania mexicana parasite causes chronic non-healing cutaneous lesions in humans and mice with poor parasite control. The mechanisms preventing the development of a protective immune response against this parasite are unclear. Here we provide data demonstrating that parasite sequestration by neutrophils is responsible for disease progression in mice. Within hours of infection L. mexicana induced the local recruitment of neutrophils, which ingested parasites and formed extracellular traps without markedly impairing parasite survival. We further showed that the L. mexicana-induced recruitment of neutrophils impaired the early recruitment of dendritic cells at the site of infection as observed by intravital 2-photon microscopy and flow cytometry analysis. Indeed, infection of neutropenic Genista mice and of mice depleted of neutrophils at the onset of infection demonstrated a prominent role for neutrophils in this process. Furthermore, an increase in monocyte-derived dendritic cells was also observed in draining lymph nodes of neutropenic mice, correlating with subsequent increased frequency of IFN.-secreting T helper cells, and better parasite control leading ultimately to complete healing of the lesion. Altogether, these findings show that L. mexicana exploits neutrophils to block the induction of a protective immune response and impairs the control of lesion development. Our data thus demonstrate an unanticipated negative role for these innate immune cells in host defense, suggesting that in certain forms of cutaneous leishmaniasis, regulating neutrophil recruitment could be a strategy to promote lesion healing.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Immunology

Established and emerging roles for mitochondria in neutrophils

Shuang Peng, Jian Gao, Darko Stojkov, Shida Yousefi, Hans-Uwe Simon

Summary: Neutrophils, the most abundant innate immune cells in human blood, have been overlooked in terms of their mitochondria function. However, growing evidence shows that mitochondria play a crucial role in various aspects of neutrophil biology, from development to chemotaxis, effector function, and cell death. Mitochondria and their components can also be released by neutrophils to eliminate infection and shape immune response. This review highlights the importance of mitochondria in modulating neutrophil phenotype and function during infection and inflammation, and discusses the potential and challenges of exploiting mitochondria in neutrophils for disease treatment.

IMMUNOLOGICAL REVIEWS (2023)

Article Biochemistry & Molecular Biology

Transcriptional Insights of Oxidative Stress and Extracellular Traps in Lung Tissues of Fatal COVID-19 Cases

Aref Hosseini, Darko Stojkov, Timothee Fettrelet, Rostyslav Bilyy, Shida Yousefi, Hans-Uwe Simon

Summary: Neutrophil extracellular traps (NETs) and oxidative stress play important roles in the immune defense against pathogens. However, impaired clearance of NETs in the lungs of COVID-19 patients may contribute to severe respiratory syndrome infection. Through RNA sequencing (RNA-seq) and immunofluorescence and immunohistochemistry methods, the study identified increased oxidative stress and viral-related signaling pathways in COVID-19 patients' lungs. Excess neutrophil infiltration and NET formation, with oxidized extracellular DNA co-localizing with myeloperoxidase (MPO), were observed. The lipid peroxidation marker 4-hydroxynonenal (4-HNE) showed high colocalization with NETs and correlated with lung neutrophil infiltration, suggesting its potential as a marker for identifying NETs and disease severity. Local inhalation therapy to reduce lipid oxidation and NETs may benefit severely infected patients.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

NET formation is independent of gasdermin D and pyroptotic cell death

Darko Stojkov, Meike J. Claus, Evelyne Kozlowski, Kevin Oberson, Olivier P. Scharen, Charaf Benarafa, Shida Yousefi, Hans-Uwe Simon

Summary: Neutrophil extracellular traps (NETs) are released by neutrophils as DNA scaffolds coated with granule proteins to ensnare and kill bacteria. The formation of NETs can occur through independent molecular pathways in response to various stimuli. It has been thought that NET release is associated with lytic cell death, but live neutrophils can release antimicrobial NETs rapidly. Gasdermin D (GSDMD), which causes pyroptotic death in macrophages, is believed to be essential for NET formation in neutrophils. However, the study found that GSDMD is not required for NET formation and that viable neutrophils can form NETs after inflammasome activation through both canonical and noncanonical signaling pathways.

SCIENCE SIGNALING (2023)

Article Immunology

Selective STING stimulation in dendritic cells primes antitumor T cell responses

Bakhos Jneid, Aurore Bochnakian, Caroline Hoffmann, Fabien Delisle, Emeline Djacoto, Philemon Sirven, Jordan Denizeau, Christine Sedlik, Yohan Gerber-Ferder, Frederic Fiore, Ramazan Akyol, Carine Brousse, Robert Kramer, Ian Walters, Sylvain Carlioz, Helene Salmon, Bernard Malissen, Marc Dalod, Eliane Piaggio, Nicolas Manel

Summary: Activation of STING in immunogenic tumors can induce antitumor T cell response, but it remains unclear how to apply it in nonimmunogenic tumors. This study showed that intratumoral delivery of cGAMP-VLP activated T cells and reduced tumor regulatory T cells, synergizing with PD1 blockade. However, intratumoral administration of the synthetic CDN ADU-S100 caused tumor necrosis and systemic T cell activation, but depleted immune cells and minimally primed circulating tumor-specific T cells. Thus, cell targeting of STING stimulation shapes the antitumor T cell response and provides a strategy to enhance T cell-targeted immunotherapy.

SCIENCE IMMUNOLOGY (2023)

Review Allergy

Eosinophils from A to Z

Lea Gigon, Timothee Fettrelet, Shida Yousefi, Dagmar Simon, Hans-Uwe Simon

Summary: Eosinophils are bone marrow-derived granulocytes that increase in number during type 2 inflammatory diseases. They migrate to various tissues and organs and have multiple functions through the synthesis and release of granule proteins and pro-inflammatory mediators. The functional role of eosinophils is still debated but they may play a role in host defense and tissue homeostasis.

ALLERGY (2023)

Article Biology

PTPN22 R620W gene editing in T cells enhances low-avidity TCR responses

Warren Anderson, Fariba Barahmand-pour-Whitman, Peter S. Linsley, Karen Cerosaletti, Jane H. Buckner, David J. Rawlings, Bernard Malissen

Summary: A genetic variant in the PTPN22 gene increases the risk for multiple autoimmune diseases and affects T cell regulation and activation. Using gene editing, researchers created T cells with different PTPN22 variants and found that the risk variant and PTPN22 knockout both led to increased T cell activation. They also observed enhanced signaling and proliferation in T cells with self-reactive T cell receptors lacking PTPN22 function. These findings suggest that PTPN22 rs2476601 contributes to autoimmunity risk by promoting TCR signaling and activation in mildly self-reactive T cells.

ELIFE (2023)

Article Oncology

Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors

Clemence Demerle, Laurent Gorvel, Marielle Mello, Sonia Pastor, Clara Degos, Ana Zarubica, Fabien Angelis, Frederic Fiore, Jacques A. Nunes, Bernard Malissen, Laurent Greillier, Geoffrey Guittard, Herve Luche, Fabrice Barlesi, Daniel Olive

Summary: The study found that anti-HVEM18-10 can enhance the activity of human αβ-T cells and trigger T cell activation in the presence of PD-L1-negative cells. Anti-HVEM18-10 treatment inhibits the growth of HVEM-positive tumors in mouse models and promotes the presence of effector memory CD4+ T cells while suppressing exhausted CD8+ T cells and regulatory T cells.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2023)

Article Biology

An OMA1 redox site controls mitochondrial homeostasis, sarcoma growth, and immunogenicity

Richard Miallot, Virginie Millet, Yann Groult, Angelika Modelska, Lydie Crescence, Sandrine Roulland, Sandrine Henri, Bernard Malissen, Nicolas Brouilly, Laurence Panicot-Dubois, Renaud Vincentelli, Gerlind Sulzenbacher, Pascal Finetti, Aurelie Dutour, Jean-Yves Blay, Francois Bertucci, Franck Galland, Philippe Naquet

Summary: Aggressive tumors often have dysfunctional mitochondria. OMA1 mediates fission of mitochondria in response to oxidative stress through cleavage of the fusion effector OPA1. In this study, mutation of cysteine 403 in OMA1 impaired mitochondrial responses to stress, resulting in reduced ATP production, resistance to apoptosis, and enhanced mitochondrial DNA release. Inactivation of OMA1 increased anti-tumor immunity and may enhance sarcoma immunogenicity.

LIFE SCIENCE ALLIANCE (2023)

Article Immunology

Defective LAT signalosome pathology in mice mimics human IgG4-related disease at single-cell level

Anais Joachim, Rudy Aussel, Lena Gelard, Fanghui Zhang, Daiki Mori, Claude Gregoire, Sergio Villazala Merino, Mauro Gaya, Yinming Liang, Marie Malissen, Bernard Malissen

Summary: Mice with a loss-of-function mutation in the LAT adaptor (Lat(Y136F)) develop an autoimmune and type 2 inflammatory disorder called defective LAT signalosome pathology (DLSP). Through single-cell omics analysis, it was found that T follicular helper cells, CD4+ cytotoxic T cells, activated B cells, and plasma cells are present in Lat(Y136F) spleen and lung. This cell constellation is similar to the cell types involved in IgG4-related disease (IgG4-RD), indicating that Lat(Y136F) DLSP can serve as a model for IgG4-RD.

JOURNAL OF EXPERIMENTAL MEDICINE (2023)

Article Biology

The coenzyme A precursor pantethine enhances antitumor immunity in sarcoma

Richard Miallot, Virginie Millet, Anais Roger, Romain Fenouil, Catherine Tardivel, Jean-Charles Martin, Laetitia Shintu, Paul Berchard, Juliane Sousa Lanza, Bernard Malissen, Sandrine Henri, Sophie Ugolini, Aurelie Dutour, Pascal Finetti, Francois Bertucci, Jean-Yves Blay, Franck Galland, Philippe Naquet

Summary: The study found that pantethine can inhibit tumor growth by enhancing the function of the immune system. Pantethine can promote the polarization of myeloid and dendritic cells towards enhanced antigen presentation pathways and improve the development of CD8+ T cells with immune effector activity. However, immune cell exhaustion limits the therapeutic effect of pantethine.

LIFE SCIENCE ALLIANCE (2023)

Meeting Abstract Oncology

Systematic immune-profiling of immune-deficient mouse models: A rational to select ideal host for tumor implantation

Herve Luche, Lillia Hadjem, Marielle Mello, Priscilla Canavese, Fabien Angelis, Anais Joachim, Sylvie Bouilly, Frederic Guinut, Frederic Fiore, Bernard Malissen, Ana Zarubica, Erwan Corcuff

CANCER RESEARCH (2023)

Meeting Abstract Oncology

Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors

Laurent Gorvel, Clemence Demerle, Marielle Mello, Sonia Pastor, Clara Degos, Ana Zarubica, Fabien Angelis, Frederic Fiore, Jacques Nunes, Bernard Malissen, Laurent Greillier, Geoffrey Guittard, Herve Luche, Fabrice Barlesi, Daniel Olive

CANCER RESEARCH (2023)

Review Oncology

Role of Patient-Derived Models of Cancer in Translational Oncology

K. F. Idrisova, H. -U. Simon, M. O. Gomzikova

Summary: It has been discovered that traditional tumor-derived cell lines do not accurately replicate the drug response and behavior of real human cancers. Consequently, more reliable tumor models that mimic the heterogeneity and patho-physiology of patient tumors are being developed. This review aims to outline the current patient-derived models of cancer, discuss their pros and cons, and highlight the progress being made in clinical trials and research in this field.

CANCERS (2023)

No Data Available